V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 200003503 | 200019174 | null | null | null | null | 2018-06-25 | null | null | null | TRIAL UNSPECIFIED | 100917893 |
| 200005062 | 200019177 | null | 60 | Palliative (P) | null | 2022-02-07 | null | null | null | BINIMETINIB + ENCORAFENIB | 100644329 |
| 200005167 | 200019178 | null | 88.1 | Palliative (P) | null | 2022-02-19 | null | null | null | BINIMETINIB + ENCORAFENIB | 101209454 |
| 200006596 | 200019180 | 1.7 | null | null | null | 2020-03-22 | null | null | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101751698 |
| 200006828 | 200019182 | 1.8 | 72.4 | 03 | null | 2020-04-08 | null | null | null | CAPECITABINE + IRINOTECAN | 100839905 |
| 200003163 | 200019184 | 1.81 | 110 | Palliative (P) | null | 2017-12-15 | null | null | N | IPILIMUMAB | 101119163 |
| 200004055 | 200019196 | 1.83 | 69.8 | null | null | 2019-02-27 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 101716870 |
| 200005026 | 200019199 | 1.72 | 98 | null | null | 2019-01-05 | PEMBROLIZUMAB | null | null | PEMBROLIZUMAB | 100786268 |
| 200005696 | 200019203 | 1.56 | 90 | null | 2019-06-19 | 2019-07-10 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 101560990 |
| 200005726 | 200019204 | null | null | null | null | 2022-04-20 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 101273939 |
| 200006088 | 200019206 | 0 | 0 | null | 2021-12-01 | 2021-12-04 | NIVOLUMAB | 02 | null | NIVOLUMAB | 101205997 |
| 200006296 | 200019207 | 1.78 | 103 | Palliative (P) | 2020-10-30 | 2020-11-29 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100441635 |
| 200006456 | 200019209 | 1.77 | 122.4 | Adjuvant (A) | 2021-11-08 | 2022-02-03 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101531999 |
| 200006508 | 200019210 | 1.61 | 61.5 | null | 2020-08-18 | 2021-03-28 | DABRAFENIB + TRAMETINIB | 02 | null | DABRAFENIB + TRAMETINIB | 101218751 |
| 200006534 | 200019211 | 1.8 | 94.7 | 02 | 2018-11-06 | 2019-10-22 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101539125 |
| 200006695 | 200019214 | 1.5 | 82 | null | 2021-08-21 | 2022-03-26 | NIVOLUMAB | 02 | null | NIVOLUMAB | 101845791 |
| 200006716 | 200019216 | 1.57 | 87 | Palliative (P) | 2021-03-11 | 2022-02-07 | DABRAFENIB + TRAMETINIB | 02 | N | DABRAFENIB + TRAMETINIB | 101121717 |
| 200006820 | 200019219 | 1.75 | 78.8 | Palliative (P) | 2020-01-02 | 2020-01-07 | DABRAFENIB + TRAMETINIB | 02 | N | DABRAFENIB + TRAMETINIB | 100675217 |
| 200006850 | 200019220 | 0 | 0 | null | 2018-10-20 | 2018-11-15 | DABRAFENIB + TRAMETINIB | 02 | null | DABRAFENIB + TRAMETINIB | 100964006 |
| 200006912 | 200019222 | 1.72 | 59.65 | Palliative (P) | null | 2022-05-18 | null | null | N | IPILIMUMAB + NIVOLUMAB | 101279586 |
| 200006956 | 200019225 | 1.62 | null | null | 2019-12-20 | 2020-04-18 | null | 02 | null | IPILIMUMAB + NIVOLUMAB | 100673898 |
| 200006982 | 200019226 | 1.68 | null | null | null | 2017-10-25 | null | null | null | TRASTUZUMAB | 100078609 |
| 200002361 | 200019232 | 1.7 | 110.8 | Palliative (P) | null | 2021-02-01 | null | null | null | DABRAFENIB | 100126973 |
| 200003503 | 200019233 | null | 80.5 | null | 2018-05-23 | 2018-06-25 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100917893 |
| 200005167 | 200019235 | null | null | null | null | 2022-02-19 | null | null | null | IPILIMUMAB | 101209454 |
| 200006828 | 200019236 | null | null | null | null | 2020-05-18 | null | null | null | DABRAFENIB | 100839905 |
| 200003794 | 200019243 | 1.62 | null | null | null | 2019-07-24 | PEMBROLIZUMAB | null | null | PEMBROLIZUMAB | 101324737 |
| 200005026 | 200019245 | null | null | null | 2018-12-11 | 2019-01-06 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 100786268 |
| 200005038 | 200019246 | null | 112.6 | null | 2018-05-06 | 2018-05-07 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 101837104 |
| 200005726 | 200019250 | null | 71.85 | null | null | 2022-05-22 | PEMBROLIZUMAB | null | null | PEMBROLIZUMAB | 101273939 |
| 200006296 | 200019251 | 1.55 | 71.5 | null | null | 2020-12-09 | PEMBROLIZUMAB | null | null | PEMBROLIZUMAB | 100441635 |
| 200006508 | 200019252 | null | null | null | 2021-04-22 | 2021-04-22 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 101218751 |
| 200006534 | 200019253 | 1.62 | 0 | null | null | 2019-11-05 | DABRAFENIB + TRAMETINIB | 02 | null | DABRAFENIB + TRAMETINIB | 101539125 |
| 200000117 | 200019261 | null | null | null | 2016-12-09 | 2019-07-16 | null | null | null | IPILIMUMAB | 100271704 |
| 200003503 | 200019265 | null | 79 | Palliative (P) | null | 2018-06-25 | null | null | null | INTERIM TRIAL | 100917893 |
| 200006534 | 200019274 | 1.72 | 70 | null | 2019-10-23 | 2019-11-05 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 101539125 |
| 200006982 | 200019279 | null | 69 | Adjuvant (A) | 2017-10-12 | 2017-11-30 | PEMBROLIZUMAB | null | N | PEMBROLIZUMAB | 100078609 |
| 200002361 | 200019280 | 1.76 | 79.3 | Palliative (P) | 2021-05-16 | 2021-06-12 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100126973 |
| 200003503 | 200019281 | 1.57 | 78 | Palliative (P) | 2018-04-19 | 2018-12-04 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100917893 |
| 200005062 | 200019282 | 1.82 | 105.8 | Palliative (P) | 2022-03-26 | 2022-03-26 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100644329 |
| 200002349 | 200019284 | 0 | 49 | null | 2020-01-21 | 2020-01-21 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 101046537 |
| 200006296 | 200019285 | 1.7 | 95.7 | null | 2020-12-16 | 2020-12-21 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 100441635 |
| 200006982 | 200019288 | 1.6 | null | null | null | 2017-10-14 | null | null | null | IPILIMUMAB + NIVOLUMAB | 100078609 |
| 200002349 | 200019291 | 1.63 | 105 | null | null | 2020-01-21 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 101046537 |
| 200006982 | 200019293 | 1.54 | 69 | null | 2017-10-12 | 2017-10-27 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100078609 |
| 200002361 | 200019294 | null | 59.65 | null | 2022-03-20 | 2022-03-31 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100126973 |
| 200005062 | 200019295 | 1.84 | null | null | null | 2022-05-23 | null | null | null | DABRAFENIB | 100644329 |
| 200002349 | 200019300 | 1.63 | 89.6 | Palliative (P) | 2020-04-19 | 2020-04-22 | DABRAFENIB + TRAMETINIB | 02 | N | DABRAFENIB + TRAMETINIB | 101046537 |
| 200002349 | 200019302 | null | null | null | null | 2020-06-22 | null | null | null | IPILIMUMAB + NIVOLUMAB | 101046537 |
| 210000033 | 210000033 | null | null | null | 2018-09-16 | 2018-12-07 | Docetaxel 100mg/m2 (21 day) | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101688678 |